Press Releases< /span>
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Oct 30, 2013
Revenue increases to $5.6 million and earnings per share rise to $0.14 Toronto Stock Exchange Symbol: DND MISSISSAUGA,, ON, Oct. 30, 2013 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: DND) ("Cipher")...
-
Oct 22, 2013
Cipher Pharmaceuticals Inc. (TSX: DND) (OTC: CPHMF), today announced it will host a conference call for its Q3 2013 financial results on Wednesday, October 30, 2013. Q3 2013 CONFERENCE CALL WHEN:...
-
Sep 19, 2013
Cipher Pharmaceuticals Inc. (TSX: DND) ("Cipher") today announced that its sales and distribution partner, Ranbaxy Laboratories Inc. ("Ranbaxy") has received a Paragraph IV Certification Notice of...
-
Jul 31, 2013
Revenue increases to $5.5 million; Company records earnings per share of $0.13 Toronto Stock Exchange Symbol: DND MISSISSAUGA, ON, July 31, 2013 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: DND)...
-
Jul 17, 2013
Cipher Pharmaceuticals Inc. (TSX: DND) (OTC: CPHMF), today announced it will host a conference call for its Q2 2013 financial results on Wednesday, July 31, 2013. Q2 2013 CONFERENCE CALL WHEN:...
-
Jul 2, 2013
At the 88th annual Canadian Dermatology Association Conference held in Quebec City over the July 1st weekend, Cipher Pharmaceuticals Inc. (TSX: DND) ("Cipher") announced the Canadian launch of...
-
May 3, 2013
- Revenue increases 82%, Company records earnings of $0.06 per share - Toronto Stock Exchange Symbol: DND MISSISSAUGA, ON, May 3, 2013 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: DND); (OTC: CPHMF)...
-
Apr 29, 2013
Cipher Pharmaceuticals Inc. (TSX: DND; OTC: CPHMF) today announced it has entered into a definitive distribution and supply agreement with Tecnofarma International Ltd. ("Tecnofarma") under which...
-
Apr 15, 2013
Cipher Pharmaceuticals Inc. (TSX: DND; OTC: CPHMF) today announced it will host a conference call for its Q1 2013 financial results and hold its Annual and Special Meeting of Shareholders on...
-
Mar 1, 2013
- Revenue increases 137%, Company records earnings of $0.10 per share - Toronto Stock Exchange Symbol: DND MISSISSAUGA, ON, March 1, 2013 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: DND; OTC: CPHMF)...
-
Feb 21, 2013
Cipher Pharmaceuticals Inc. (TSX: DND) (OTC: CPHMF), today announced it will host a conference call for its Q4 and Year-End 2012 financial results on Friday, March 1, 2013. Q4 AND YEAR-END 2012...
-
Jan 3, 2013
Cipher Pharmaceuticals Inc. (TSX: DND) (OTC: CPHMF), announced today that Larry Andrews, President and Chief Executive Officer, is presenting at Biotech Showcase™ 2013, which is being held in...
-
Nov 26, 2012
- Novel product provides valuable new treatment option for severe recalcitrant nodular acne - Toronto Stock Exchange Symbol: DND MISSISSAUGA, ON, Nov. 26, 2012 /CNW/ - Cipher Pharmaceuticals Inc....
-
Nov 20, 2012
Product to be launched as Epuris™ Toronto Stock Exchange Symbol: DND MISSISSAUGA, ON, Nov. 20, 2012 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: DND; OTC: CPHMF) announced today that Health Canada...
-
Oct 24, 2012
Cipher Pharmaceuticals Inc. (TSX: DND) (OTC: CPHMF) today announced its financial and operational results for the three months ended September 30, 2012 ("Q3 2012"). Q3 2012 Summary Achieved...
-
Oct 4, 2012
Cipher Pharmaceuticals Inc. (TSX: DND; OTC: CPHMF) today announced it will host a conference call for its Q3 2012 financial results on Wednesday, October 24, 2012 at 8:30AM ET. Q3 2012 CONFERENCE CALL
-
Aug 27, 2012
Cipher Pharmaceuticals Inc. (TSX: DND; OTC: CPHMF), announced today that Larry Andrews, President and Chief Executive Officer, is presenting at the Rodman & Renshaw 14th Annual Healthcare...
-
Aug 7, 2012
- In-license agreement for the Betesil® Patch to treat inflammatory skin conditions - Toronto Stock Exchange Symbol: DND MISSISSAUGA, ON, Aug. 7, 2012 /CNW/ - Cipher Pharmaceuticals Inc., (TSX:...
-
Jul 25, 2012
- Results highlighted by solid revenue growth and FDA approval of CIP-ISOTRETINOIN - Toronto Stock Exchange Symbol: DND MISSISSAUGA, ON, July 25, 2012 /CNW/ - Cipher Pharmaceuticals Inc. (TSX:...
-
Jul 4, 2012
Cipher Pharmaceuticals Inc. (TSX: DND; OTC: CPHMF) today announced it will host a conference call for its Q2 2012 financial results on Wednesday, July 25, 2012. Q2 2012 CONFERENCE CALL WHEN:...
-
Jun 4, 2012
Cipher Pharmaceuticals Inc. (TSX: DND; OTC: CPHMF), announced today that Larry Andrews, President and Chief Executive Officer, is presenting at the Bloom & Burton Healthcare Investor Conference,...
-
May 28, 2012
Product to be launched as Absorica™ Toronto Stock Exchange Symbol: DND MISSISSAUGA, ON, May 27, 2012 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: DND; OTC: CPHMF.PK) announced today that the U.S....
-
May 27, 2012
Product to be launched as Absorica™ Toronto Stock Exchange Symbol: DND MISSISSAUGA, ON, May 27, 2012 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: DND; OTC: CPHMF.PK) announced today that the U.S....
-
May 4, 2012
Cipher Pharmaceuticals Inc. (TSX: DND; OTC: CPHMF.PK) today announced its financial and operational results for the three months ended March 31, 2012 ("Q1 2012"). Q1 2012 Summary Achieved...
-
Apr 25, 2012
Cipher Pharmaceuticals Inc. (TSX: DND; OTC: CPHMF.PK) today announced it will host a conference call for its Q1 2012 financial results and hold its Annual Meeting of Shareholders on Friday, May 4,...